Case Study: AstraZeneca improves construction safety and collaboration with 3D Repo

AstraZeneca identifies 40 construction risks with 3D Repo

AstraZeneca, a global pharmaceutical company, faced the challenge of managing complex construction risks and improving collaboration during the expansion of its largest UK manufacturing plant. To address this, they partnered with vendor 3D Repo to implement its SafetiBase platform as part of the Discovering Safety programme, aiming to visualize risks within a 3D model and enhance their safety protocols.

The solution from 3D Repo involved creating a cloud-based 3D model to visualize construction risks, which allowed for earlier and more effective stakeholder collaboration. This led to significant results, including the early identification of 40 non-obvious risks and design changes that saved both time and money. For example, the team relocated climate control plant equipment from the roof to the ground floor after visualizing the safety risks, preventing potential delays. AstraZeneca reported improved communication and plans to use 3D Repo's SafetiBase on future projects.

AstraZeneca